AGICC Investigators Meeting at ASCO 2012

Dr. Lawrence Leichman, AGICC Medical Director, will lead an Investigators’ Meeting – June 2, 2012 (11:30am – 1:30 pm) that includes some of the country’s premier GI cancer experts. The meeting agenda will feature updates and protocol discussions on current studies, as well as presentations by companies collaborating with AGICC on clinical trials.

Continue reading

AGICC to Exhibit at GI ASCO and Host Meet and Greet Reception

The Aptium Oncology GI Cancer Consortium (AGICC) will have a presence at the 2011 Gastrointestinal Cancers Symposium, 20-22, 2011 at The Moscone West Building in San Francisco. The symposium, also known as the GI ASCO, will feature more than 600 abstracts on the latest research in gastrointestinal cancers.

Continue reading

CRITERIUM, Inc. CRO Announces New Acquisition – Former Aptium Oncology Cancer Consortium Finds a New Home

Criterium, Inc., a full-service, global CRO, is pleased to announce the acquisition of the former Aptium Oncology’s CORE Science Solutions (CSS) Cancer Consortium Groups consisting of AGICC and AMyC as the newest members of Criterium’s Pharma services companies. Criterium is proud to include AGICC and AMyC, two academic cancer research consortia in its family of companies. Important and well-known institutions and investigators are actively collaborating as part of the consortia.

Continue reading

AGICC’s Dr. Lawrence Leichman Presents Two Posters at ASCO-NCI-EORTC Annual Meeting

Dr. Lawrence Leichman, Director of the Aptium Oncology GI Cancer Consortium (AGICC), presented two posters at the ASCO-NCI-EORTC Annual Meeting held in Hollywood, Florida October 17-18, 2010.

The posters are the first publications from the AGICC trials. The first poster, titled ‘DNA Repair and Apoptosis,’ was authored by Dr. Leichman and members of the Consortium. The second poster pertains to a Phase II study of a combination compound for advanced colorectal cancer.

Continue reading

Aptium Oncology Highlights AGICC and AMyC at the 2010 ASCO Meeting

Aptium Oncology’s Research Department featured two consortia at the recent ASCO 2010 Annual Meeting in Chicago which was aptly themed ‘Advancing Quality through Innovation.’ More than 30,000 cancer specialists from around the world gather at this premier meeting annually to discuss the latest innovations in research, quality, practice and technology in cancer.

Continue reading

Join us for our Myeloma and GI Cancer Consortia Reception

Join us for our Myeloma and GI Cancer Consortia Reception 

Friday, June 4, 2010 6:30 – 8:30 pm

Affinia Chicago • C-View – Rooftop Lounge
166 East Superior Street
Chicago, IL 60611

Please RSVP by Friday, May 21 to Rhonda Hopkins at rhopkins@aptiumoncology.com.
Bus Route from the Convention Center: Gate 3 Route 6

Network with our investigators. Visit our booth #22036.

View more information (PDF).

Macdonald Editorial in GI Cancer Research Journal

An editorial by Dr. John S. Macdonald, Aptium Oncology’s Chief Medical Officer, was recently published in the GI Cancer Research Journal, the official journal of the International Society of Gastrointestinal Oncology. The editorial is titled Adopting Postoperative Chemoradiotherapy in Resected Gastric Cancer.

Continue reading